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Abstract
Ligand binding to tumor necrosis factor receptor-I (TNFRI) can promote cell survival or activate the apoptotic caspase
cascade. Cytoplasmic interaction of TNFRI with TRAF2 and RIP allows for the activation of JNK and NFUB pathways.
Alternatively, a carboxy terminal death domain protein interaction motif can recruit TRADD, which then recruits FADD/
MORT1, and finally procaspase 8. Aggregation of these components form a death inducing signaling complex, leading to the
cleavage and activation of caspase 8. We have found that during apoptosis human TNFRI protein is lost in a caspase-
dependent manner. The cytoplasmic tail of human TNFRI was found to be susceptible to caspase cleavage but not by
caspase 8. Instead, the downstream executioner caspase 7 was the only caspase capable of cleaving TNFRI, in vitro.
Identification and characterization of the cleavage site revealed a derivative of the classic EXD motif that incorporates a
glutamate (E) in the P1 position. Using several criteria to establish that caspase activity was responsible for cleavage at this
site, we confirmed that caspase 7 can cleave at a GELE motif. Mutation of the cleavage site prevented the apoptosis-
associated cleavage of TNFRI. This ability of caspase 7 to cleave at a non-EXD or -DXXD motif suggests that the specificity
of caspases may be broader than is currently held. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Metazoan organisms use programmed cell death
(PCD) to regulate cell numbers during development
and for homeostasis [1]. The regulation of apoptosis
is tightly controlled since too much death can lead to
insurmountable de¢ciencies, as with neurodegenera-
tive disorders [2] ; whereas, too little apoptosis can
lead to hyperplasia and lymphoproliferative disor-
ders [3]. Most PCD occurs through an active process,
called apoptosis, whereby the cells are removed with-
out releasing potentially toxic cytoplasmic contents
that may stimulate an immunogenic response. Dur-
ing apoptosis, the cell typically shrinks, fragments
DNA, condenses chromatin, and blebs into small
apoptotic bodies. These morphological changes
have each been attributed to the actions of a family
of cysteinyl-dependent, aspartate-speci¢c proteinases,
called caspases [4]. Metazoan cells constitutively ex-
press caspases as zymogens proforms, which are ac-
tivated through cleavage by other, previously acti-
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vated, caspases. Active caspases cleave after speci¢c
motifs, either DXXD or EXD, most often when fol-
lowed by S, T, A, N, G or C [5]. The ¢rst, or ini-
tiator, caspases are activated in specialized macromo-
lecular complexes, called apoptosomes and death
inducing signaling complexes (DISCs). Once acti-
vated, initiator caspases can then cleave and activate
the more plentiful downstream ‘executioner’ caspases
3, 6 and 7. Ligand binding of death receptors such as
Fas, CD40 and tumor necrosis factor receptor-I
(TNFRI) can form a DISC via death domain (DD)
protein interaction motifs. Ligand-bound TNFRI
uses DD interactions to bind TRADD, which then
recruits FADD/MORT1 and subsequently procas-
pase 8 [6,7]. Close juxtaposition of several procaspase
8 proteins allows for trans-cleavage resulting in fully
active caspase 8 that can then cleave more procas-
pase 8. Active caspase 8 also cleaves and activates
caspases 3, 6 and 7.
Inhibitors of apoptosis proteins (IAPs) negatively
regulate apoptosis by inhibiting caspase activity [8].
In Drosophila, cell death is initiated by the proteins
Reaper, Hid and Grim, which block IAP activity
resulting in the disinhibition of caspases [9,10]. It
has been suggested that low levels of caspase activity
may occur in mammalian cells on a regular basis,
and that IAPs squelch these pockets of caspase ac-
tivity to prevent precocious apoptosis. Indeed, the
mitochondrial release of a pan-IAP inhibitor, Smac/
DIABLO, has recently been shown as required for
some apoptotic stimuli [11,12]. Although nearly 50
caspase substrates have been described, the conse-
quences of cleavage are known for only some of
these proteins, including the caspases themselves,
ICAD/CAD, PARP, acinus, gelsolin, and fodrin,
each of which play critical roles in the morphological
characteristics of apoptosis [1]. The cumulative ef-
fects of low level and/or short-lived caspase activities
on cellular homeostasis, and signaling, have not been
well studied. Recently, we and others have suggested
that caspase cleavage of some substrates, such as
DCC and Atrophin-1, can feedback to a¡ect the
rapidity and e⁄cacy of apoptotic stimuli [13,14].
Ligand-bound TNFRI can also activate JNK and
NFUB signaling pathways through cytoplasmic inter-
actions with TRAF2. The subsequent recruitment
and activation of IKK phosphorylates IUB, causing
ubiquitin-mediated degradation [15]. Once freed of
IUB, NFUB translocates to the nucleus where it ef-
fects the transcription of many genes [16]. TNFRI-
mediated NFUB activation is anti-apoptotic [17].
Further, TRAF2 recruitment to TNFRI can also ac-
tivate the JNK pathway via MEK kinase 1 [18,19].
Interactions between these pathways can a¡ect sig-
naling and apoptosis as caspase 8 cleavage of RIP
will prevent NFUB activation and prompt TNF-in-
duced apoptosis [20].
Here we have investigated if there may be signal-
halting feedback directly to TNFRI. In human cells,
TNFRI protein was found to be lost during apopto-
sis in a caspase-dependent manner. We examined the
susceptibility of TNFRI to caspase cleavage in vitro
using recombinant caspases. The cytoplasmic tail of
TNFRI was cleaved by the executioner caspase 7,
but not caspase 3 nor caspase 8 even though the
latter is activated in the TNFRI DISC. Further, we
have identi¢ed and characterized the site of cleavage
by caspase 7, and found it to be a non-consensus
motif. The susceptibility of this motif to caspase
cleavage was further investigated using a £uorogenic
peptide that included this motif. Finally, a cleavage
product of TNFRI was observed in transfected cells
during apoptosis, but no such product was observed
when this cleavage site was mutated.
2. Methods and materials
2.1. Cell culture
Jurkat cells (human) were maintained in DMEM
supplemented with 10% FCS, penicillin/streptomycin
and L-glutamine. Apoptosis was induced with UV or
10 WM staurosporine (STS), with and without
zVAD-fmk (100 WM). Protein extracts were prepared
at 0, 2 or 4 h, as previously described [21]. Protein
samples (20 Wg) were resolved on sodium dodecyl
sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) and blotted to nitrocellulose. Blots were
probed with anti-TNFRI antibody speci¢c for the
amino terminus (1:1000; Santa Cruz Biotech, Santa
Cruz, CA).
Human embryonic kidney (293) cells were trans-
fected with 5 Wg/6 cm dish of expression plasmids
containing L-galactosidase (LGal), wild-type (wt)
TNFRI-IC or E260Q-TNFRI-IC, using Geneporter
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(Gene Therapy System, San Diego, CA) following
the manufacturer’s protocol. The cells were main-
tained and transfected in RPMI supplemented
with 5% FCS, penicillin, streptomycin, and L-gluta-
mine. After 24 h, the cells were washed o¡ the dish
in PBS, which was pooled with the media, and the
cells spun down for 5 min at 1000Ug. The cell pellet
was resuspended in 200 Wl of protein sample bu¡er
and boiled for 5 min. 50 Wl of each sample were
resolved on an SDS^PAGE gel, blotted to Hybon-
dECL, blocked and probed with an antibody
(1:1000) speci¢c for the carboxy-terminus of
TNFRI (Santa Cruz Biotech). After HRP-conju-
gated secondary antibody incubation bands were
resolved using a chemiluminescence kit (Pierce,
Rockford ,IL). The blot was stripped and reprobed
with anti-actin, as above.
2.2. Molecular biology
The cytoplasmic domain of human TNFRI was
cloned from a human brain cDNA library using
the polymerase chain reaction (PCR), with primers
designed to provide a Kozak sequence at the 5P end.
The PCR product was ligated into an expression
plasmid, pCR3.1 (Invitrogen, Carlsbad CA), and
con¢rmed by DNA sequencing. Site-directed muta-
genesis was accomplished using the Quickchange kit
(Stratagene, La Jolla, CA). Mutations were con-
¢rmed with DNA sequencing.
2.3. In vitro caspase cleavages
Radioactive protein products were made from
plasmid DNA using in vitro transcription/translation
(IVT; Promega, Madison, WI), with [35S]methionine.
Caspase cleavages were performed in vitro using pu-
ri¢ed recombinant caspases (caspases 3, 6, 7 and 8
were provided by Dr. Guy Salvesen; caspase 8 was a
gift of Dr. Ben Wolf; caspase 1 was a gift of Merck),
as previously described. Brie£y, 3 Wl of IVT reaction
product was incubated (37‡C) with caspases at di¡er-
ent concentrations and times, detailed in Section 3.
Caspase reactions were carried out in 20 mM PIPES
(pH 7.2), 100 mM NaCl, 1% CHAPS, 10% sucrose,
10 mM DTT and 0.1 mM EDTA. Cleavage reaction
products were separated by SDS^PAGE, dried onto
¢lter paper and placed on X-ray ¢lm overnight.
Puri¢ed zVAD-fmk was purchased from Enzyme
Systems. Recombinant p35 and the BIR2 domain of
XIAP were provided by Dr. Guy Salvesen. The
GELE-afc peptide was custom synthesized by En-
zyme Systems. Cleavage assays were carried out in
100-mm reactions composed of 88 Wl caspase bu¡er
(20 mM PIPES (pH 7.4); 100 Wl NaCl; 10% sucrose;
0.1% CHAPS; 1 mM EDTA; 10 mM DTT added
Fig. 1. (A) Loss of TNFRI protein (p60) during apoptosis is
caspase-dependent. Protein extracts from Jurkat cells induced to
undergo apoptosis by either UV, or staurosporine (STS), at
2 and 4 h time points. The pan-caspase inhibitor zVAD-fmk
completely inhibited this loss from either apoptotic stimulus.
(B) Susceptibility of the cytoplasmic region TNFRI to caspase
cleavage in vitro. Only caspase 7 cleaved the protein. (C) In vi-
tro caspase 7 cleavage of TNFRI was time- (D) and concentra-
tion-dependent.
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immediately prior to use) and 10 Wl of 1 mg/ml
GELE-afc substrate, and 2 Wl of each caspase. Fluo-
rogenic readings were taken every 60 s for 30 min
using a Tecan SpectraFluor plate reader.
3. Results
Jurkat cells showed a loss of full length (p60)
TNFRI protein during apoptosis, induced by UV
irradiation or staurosporine (STS) (Fig. 1A). This
loss was completely abrogated by the presence of
the pan-caspase inhibitor zVAD-fmk, suggesting a
caspase-dependent mechanism.
We tested the cytoplasmic tail of TNFRI (TNFRI-
IC) for susceptibility to cleavage by several caspases
in vitro. Although caspases 1, 3, 6, and 8 were unable
to cleave the cytoplasmic region of TNFRI, caspase
7 consistently cleaved approximately 2 kDa from
TNFRI-IC (Fig. 1B). Dilution series of caspase 7
showed that cleavage was concentration-dependent
(Fig. 1C). Also, time series showed time-dependence
of TNFRI cleavage by caspase 7 (Fig. 1D).
To identify the caspase cleavage site we individu-
ally mutated each aspartate residue that could ac-
count for the fragments observed from in vitro cleav-
age (Fig. 2A). However, mutations D303N, D427N,
D429N, or D436N had no e¡ect on the observed
Fig. 3. Cleavage of TNFRI at GELE is due to caspase activity.
(A) Cleavage by caspase 7 was partially inhibited by the bacu-
lovirus caspase inhibitor p35. (B) Cleavage was completely in-
hibited by zVAD-fmk and partially inhibited by the BIR2 do-
main of XIAP.
Fig. 2. Amino acid sequence of the cytoplasmic domain of hu-
man TNFRI showing the tested mutations in outline. (A) Dele-
tion mutations 254^260 and 435^439 are marked with bars. The
end of deletion mutant vC42 is indicated with an arrow. (B^D)
Mutations of TNFRI were used to identify the site of cleavage
by caspase 7. (D) Deletion of amino acids 254^260 eliminated
the main cleavage product as did the single mutation E260Q.
(E) Homologous sequence alignment of the GELE motif in hu-
man TNFRI (middle), marked with a bar. Residues surround-
ing the caspase cleavage motif of human TNFRI were com-
pared with the same regions of rat, mouse, pig and cow
TNFRI, using MacVector software.
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caspase 7 cleavage of TNFRI (Fig. 2B). We also
tested mutations of E415Q and E419Q but those
also had no e¡ect. To test possible cleavage sites at
the carboxy terminus we deleted the last 42 amino
acids, v42; however, this did not prevent caspase 7
cleavage. Deletion of residues 254^260 did prevent
appearance of the major cleavage product. Muta-
tions within that region showed that the mutation
E260Q alone was su⁄cient to prevent cleavage.
Homologous sequence alignments showed that the
core EXE motif of GELE was conserved as VEGE in
rat and GEPE in pig (Fig. 2E). However, mouse and
cow did not have this motif and instead appear to
have 3^4 missing amino acids in direct alignment
with this site.
As caspase cleavage at a site with glutamate in the
P1 position has only been reported for the Drosophi-
la caspase DRONC [22], we used several caspase
inhibitors to con¢rm that cleavage was due to the
activity of caspase 7 and not contaminating enzymes
from the IVT. Low concentrations of zVAD-fmk (1
WM) were not su⁄cient to block caspase activation,
but higher levels (100 WM) were (Fig. 3A). The ba-
culovirus protein p35 inhibits group III caspases,
which include caspase 7. Cleavage of TNFRI by re-
combinant caspase 7 was attenuated by recombinant
p35. Although inhibition was incomplete, the caspase
inhibitory activity of the recombinant p35 used was
determined to be unstable in vitro (Salvesen, person-
al communication). A third caspase inhibitor tested
was the BIR2 domain of the caspase inhibitor XIAP
(Fig. 3B), which has been shown to be su⁄cient for
Fig. 4. Caspase cleavage of GELE-afc peptide. (A) Caspase 7 cleaved the £uorogenic peptide GELE-afc. Fluorescence intensity of the
sample containing recombinant caspase 7 (top) increased with time, whereas reactions without caspase 7 (bottom) stayed relatively
constant. (B) Caspase 3 (gray) cleaved the GELE-afc peptide similar to caspase 7 (black). (C) However, the other executioner caspase
6 (bottom) was not able the substrate compared with caspase 7 (top). (D) Caspase 8 (bottom) was also unable to cleave the GELE-
afc substrate.
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the inhibition of caspase 3 and 7 activities [23]. The
inclusion of recombinant BIR2 in cleavage reactions
also greatly reduced TNFRI cleavage by caspase 7.
Together, these ¢ndings established that caspase 7
activity was responsible for cleavage at GELE.
To provide conclusive evidence that the GELE
motif can be cleaved by caspase 7 we assayed a cus-
tom £uorogenic peptide composed of GELE-afc.
Caspase 7 was able to cleave the substrate, compared
with no-caspase controls (Fig. 4A). Although caspase
3 was unable to cleave the cytoplasmic tail of human
TNFRI protein in vitro, it was able to cleave the
GELE-afc peptide (Fig. 4B). This discrepancy may
be due to stoichiometric di¡erences between TNFRI
protein and this peptide. Within the context of the
cytoplasmic tail this GELE motif may be inaccessible
to the active site of caspase 3, but not caspase 7. The
third executioner caspase tested, caspase 6, was un-
able to cleave the GELE-afc peptide compared with
caspase 7 (Fig. 4C), which con¢rmed the TNFRI
protein cleavage assays. Although caspase 8 is acti-
vated in the TNFRI DISC, it was not able to cleave
GELE-afc, again con¢rming the cleavage studies
done with IVT cytoplasmic tail (Fig. 4D). The ability
of caspase 7 and 3 to cleave the substrate contrasted
with caspases 6 and 8, con¢rming this cleavage was
mediated by speci¢c caspase activities.
Cleavage of the intracellular regions of wt and
E260Q TNFRI were compared in vivo by the trans-
fection of expression plasmids into human embryonic
kidney 293 cells. Overexpression of wt TNFRI-IC
and E260Q both induced apoptosis after 24 h (Fig.
5B,C). This ¢nding was consistent with activity as-
cribed to carboxy terminal DD present in both con-
structs, and con¢rmed the e⁄cacy of transfection
[24]. In contrast, the transfection of 293 cells with
LGal had no e¡ect on cell survival (Fig. 5A). West-
ern blots probed with anti-TNFRI (carboxy termi-
nal) showed bands at the anticipated Mr in wt and
E260Q samples but not LGal (Fig. 5D). Full-length
TNFRI-IC was seen in both wt and E260Q trans-
fected cells, but was much more intense with E260Q.
Fig. 5. In vivo cleavage of the cytoplasmic region of TNFRI. (A) 293 cells were transfected with expression plasmid containing LGal
as a control. (B) 293 cells transfected with TNFRI-IC were apoptotic. (C) Transfection of E260Q also induced apoptosis in these cells.
(D) Whole cell lysates from A^C were separated on SDS^PAGE, blotted onto nitrocellulose and probed with anti-TNFRI (carboxyl
terminal speci¢c). No band was seen in lysates from LGal-transfected cells, but cells transfected with wt and E260Q TNFRI-IC both
showed bands consistent with full-length (IC) protein. A band of the expected cleavage size was seen in wt, but not in the E260Q mu-
tant. To con¢rm equal loading the blot was stripped and re-probed with anti-actin.
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The anticipated cleavage product expected from cas-
pase cleavage at E260 was seen only in the wt lane at
a level similar to the full length IC protein. More full
length protein in the E260Q lane may have been due
to the absence of cleavage seen with wt.
4. Discussion
Here we report that human TNFRI is cleaved by
caspases in human cells undergoing apoptosis. In vi-
tro analysis of the cytoplasmic tail of TNFRI con-
¢rmed this susceptibility to cleavage by caspase 7,
but not by caspases 1, 3, 6 or 8. This ¢nding was
unexpected as all caspase 7 substrates have been re-
ported to be susceptible to caspase 3 cleavage. How-
ever, caspase 3 was able to cleave the bare GELE-afc
peptide, perhaps due to higher accessibility than is
found within the cytoplasmic tail of TNFRI. Cas-
pase 7 cleaved the cytoplasmic tail of TNFRI in a
concentration and time-dependent manner, in vitro.
Further, using mutagenesis we identi¢ed the caspase
cleavage site as corresponding to a non-consensus
motif for caspase cleavage. A glutamate residue in
the P1 position is a variation on the standard EXD
consensus motif, changing it to EXE. Deletion or
mutation of the P1 glutamate to glutamine elimi-
nated the observed cleavage. Moreover, when the
wt and mutant constructs were over-expressed in
293 cells, only wt produced the cleavage product.
Analysis of the Drosophila caspase, DRONC, is
the only report of a caspase cleaving substrates
with glutamate in the P1 position [22]. Our ¢nding
that caspase 7 is capable of cleaving this non-con-
sensus site is the ¢rst report of a mammalian caspase
cleaving at such a site. Further, this variability in
caspase consensus may also prove to be true for oth-
er mammalian caspases. Although the physiological
signi¢cance of TNFRI cleavage by caspase 7 has yet
to be established, one role it may serve is to feedback
and prevent TNFRI generated signals from interfer-
ing with the orderly process of apoptosis initiated by
non-TNFRI stimuli. In addition to caspase activa-
tion, ligand binding of TNFRI can also lead to the
nuclear translocation/activation of NFUB, the JNK
pathway, and Raf-1 [25]. However, reports of cas-
pase activation in non-apoptotic cells suggest that
this family of proteinases may be utilized in cellular
processes aside from cell death [26]. Given the plei-
otrophic consequences of TNF-K/TNFRI engage-
ment, perhaps focal caspase activation near a site
of cell^cell contact may cause the cleavage of
TNFRI, thereby preventing TNFRI signaling from
that area.
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